期刊文献+

大黄对脓毒症的治疗作用及对血清PCT,IL-6的影响 被引量:17

The Therapeutical Effect of Rhubarb on Sepsis and PCT and IL-6
下载PDF
导出
摘要 目的:观察大黄对脓毒血症的治疗作用,结合血浆PCT及IL-6水平变化,探讨大黄的作用机制。方法:将50例入住ICU的脓毒症患者按入院时间顺序随机分为大黄组和对照组,观察两组患者APACHEII评分及血清PCT、IL-6的变化,结合患者与SIRS相关的体征等变化来统计大黄治疗有效率。结果:两组患者APACHEII评分PCT、IL-6水平:第7天大黄组IL-6水平低于对照组(P<0.05),而PCT水平及APACHEII评分显著低于对照组,差异有统计学意义(P<0.01)。大黄治疗组临床改善的有效率高于对照组,两者差异有统计学意义(P<0.05)。结论:大黄可有效抑制炎症因子释放,改善脓毒症患者全身炎症反应综合征表现。 Objective : To observe the effect of rhubarb on sepsis, and investigate its mechanism of action com- bined with PCT and IL-6 in blood plasma. Methods: 50 cases with sepsis in ICU were divided into two groups ran- domly according to admission sequence, 25 cases in each group. APACHE II score and PCT and IL-6 in blood plasma were observed in the two groups, and the effective rate of rhubarb was analyzed with statistics combined with the associated signs correlated to SIRS. Results: On the 7th day, IL-6 in treatment group was decreased ac- cording to APACHE II score, and lower than that in control group (P 〈 0. 05). So was PCT, and there was signif- icant difference between the two groups (P 〈0. O1 ). In clinic the effective rate of treatment group was higher than that of control group, and significant difference showed also between the two groups ( P 〈 0.05 ). Conclusion : Rhubarb can effectively inhibit the inflammatory factor releasing, and improve the patients'manifestation of system- ic inflammatory response syndrome.
出处 《山西中医》 2012年第7期38-39,共2页 Shanxi Journal of Traditional Chinese Medicine
基金 江苏省镇江市科技支撑计划(社会发展)项目(编号:FZ2011047)
关键词 大黄 脓毒症 IL-6 PCT 中医药疗法 sepsis, rhubarb, IL-6, PTC, TCM therapy
  • 相关文献

参考文献6

二级参考文献22

  • 1姚咏明,董胜利,于勇,盛志勇.创伤后肠道细菌/内毒素移位的发病机制与意义[J].世界感染杂志,2004,4(5):433-437. 被引量:7
  • 2王红伟.论免疫学中的阴阳观[J].中医教育,2004,23(5):48-49. 被引量:2
  • 3马涛,尤胜义.淋巴细胞凋亡、免疫抑制和脓毒症[J].国外医学(外科学分册),2005,32(1):35-38. 被引量:26
  • 4崔乃强,赵琪,葛智慧,殷宗福,靳殿功,孙新明,邱奇,张灼,张风云,房洁,吴咸中.通里攻下法治疗急腹症所致MODS的疗效观察[J].中国中西医结合外科杂志,1996,2(5):315-320. 被引量:74
  • 5Bone RC,Balk RA,Cerra FB. ACCP/SCCM definitions for sepsis and organ failure guidelines for the use of innovative therapies in sepsis[J]. Chest, 1992,101:1644- 1655.
  • 6Joan M. The role of C reactive protein in the evaluation and management of infants with suspected sepsis[J].Adv Neonatal Care,2003,3(1):3 -13.
  • 7Povoa P, Almeida E, Moreira P,et al. C-reactive protein as an in dicator of sepsis[J]. Intensive Care Med, 2008, 24: 1052-1056.
  • 8Claeys R,Vinken S,Spapen H,etal. Plasma procalcitonin and C- reactive protein in acute septic shock: clinical and biological corerlates[J]. Crit Care Med, 2002,30(4) :757-762.
  • 9Haweky PM. Mechanisms of resistance to antibiotics[J]. In tensiev Caer Med, 2000,26 : 9 -13.
  • 10Dellinger R P, Cadet J M, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock[J]. Intensive Care Meal,2005, 30 (4): 536.

共引文献302

同被引文献280

引证文献17

二级引证文献135

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部